Brii said it agreed to purchase the assets from VBI Vaccines Inc. and its creditors for $18 million. The deal gives Brii full access to the remaining IP, patents and materials related to BRII-179, an ...

VBI Vaccines (NASDAQ:VBIV) stock is rising higher on Tuesday after the commercial-stage biopharmaceutical company filed for bankruptcy last week. According to a press release from VBI Vaccines ...

CAMBRIDGE, Mass., Jan. 3, 2025 /PRNewswire/ - VBI Vaccines Inc. ("VBI" or the "Company") today announced, that, in connection with its creditor protection proceedings under the Companies ...

VBI Vaccines ( (VBIVQ) ) has shared an announcement.

By reaching an agreement with VBI and its creditor, Brii believes it has ensured the uninterrupted supply of BRII-179. The therapeutic vaccine candidate is part of the biotech’s attempts to ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor ...

VBI Vaccines Inc. has completed a restructuring process under the Companies’ Creditors Arrangement Act, resulting in the acquisition by K2 VBI Equity Trust, LLC. All common shares have been ...